Lv429
780 积分 2025-01-16 加入
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
24天前
已完结
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
1个月前
已完结
Realizing the potential of agonistic antibody immunotherapy
1个月前
已完结
Non‐Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN‐101)
1个月前
已完结
Diabodies: Molecular engineering and therapeutic applications
1个月前
已关闭
Diabodies: Molecular engineering and therapeutic applications
1个月前
已关闭
Crystal structure of a soluble CD28-Fab complex
1个月前
已完结
T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
2个月前
已完结
The Role of the immunological Synapse Formed by Cytotoxic Lymphocytes in Immunodeficiency and Anti-Tumor immunity
2个月前
已完结
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
2个月前
已完结
皖公网安备34019202002308
